Lishomwa C. Ndhlovu - Nov 24, 2021 Form 3 Insider Report for CytoDyn Inc. (CYDY)

Role
Director
Signature
/s/ Antonio Migliarese, Attorney-in-Fact
Stock symbol
CYDY
Transactions as of
Nov 24, 2021
Transactions value $
$0
Form type
3
Date filed
12/13/2021, 06:13 PM
Next filing
Sep 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYDY Stock Option (right to buy) Nov 24, 2021 Common Stock 50K $3.36 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became exercisable as to 25,000 shares on the date of grant, August 31, 2020, and as to the remaining 25,000 shares on February 28, 2021.

Remarks:

EX 24- Power of Attorney